Duan Shen

Duan Shen has a strong background in patent attorney roles, working for various companies in the biopharmaceutical industry. Duan is currently serving as the IP Director at EpimAb Biotherapeutics, Inc. since March 2020. Prior to this, they worked for Novartis Institutes for BioMedical Research (NIBR) as a Patent Attorney from April 2018 to March 2020. Before joining NIBR, Duan worked as a Patent Attorney at Novartis from February 2016 to March 2018. Duan started their career as a Patent Attorney at Shanghai Patent & Trademark Law Office, where they worked from April 2011 to February 2016. Duan also has experience as a Risk Assessor at Intertek from 2009 to 2010.

Duan Shen pursued a Ph.D. in Chemical & Biological Engineering from 2002 to 2008 at the Rensselaer Polytechnic Institute.